Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 1Lymphoma, Follicular 1Colitis, Ulcerative 1

Interventions

Exercise 126Resistance Training 15Surveys and Questionnaires 13Walking 11Methods 7High-Intensity Interval Training 7Exercise Therapy 5Diet 5methyl hydroxyethyl cellulose 4Motivational Interviewing 4Standard of Care 3Preoperative Exercise 3Nutritional Status 3Nutrition Assessment 3Cognitive Behavioral Therapy 3Behavior Therapy 3Yoga 2Wearable Electronic Devices 2Waiting Lists 2Therapeutics 2Telerehabilitation 2Self-Management 2Physical Therapy Modalities 2Observation 2Metformin 2Fitness Trackers 2Exercise Test 2Educational Status 2Diet, Mediterranean 2Counseling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Motor Activity × peficitinib × Clear all
NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed
219 enrolled
Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡